IL162103A0 - Methods of treating bacterial infections in dogs and cats - Google Patents

Methods of treating bacterial infections in dogs and cats

Info

Publication number
IL162103A0
IL162103A0 IL16210302A IL16210302A IL162103A0 IL 162103 A0 IL162103 A0 IL 162103A0 IL 16210302 A IL16210302 A IL 16210302A IL 16210302 A IL16210302 A IL 16210302A IL 162103 A0 IL162103 A0 IL 162103A0
Authority
IL
Israel
Prior art keywords
cats
dogs
methods
bacterial infections
treating bacterial
Prior art date
Application number
IL16210302A
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0130694.3A external-priority patent/GB0130694D0/en
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of IL162103A0 publication Critical patent/IL162103A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
IL16210302A 2001-12-21 2002-11-13 Methods of treating bacterial infections in dogs and cats IL162103A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB0130694.3A GB0130694D0 (en) 2001-12-21 2001-12-21 Treatment
US35996102P 2002-02-27 2002-02-27
US39893302P 2002-07-26 2002-07-26
PCT/IB2002/004741 WO2003053522A1 (en) 2001-12-21 2002-11-13 Methods of treating bacterial infections in dogs and cats

Publications (1)

Publication Number Publication Date
IL162103A0 true IL162103A0 (en) 2005-11-20

Family

ID=27256361

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16210302A IL162103A0 (en) 2001-12-21 2002-11-13 Methods of treating bacterial infections in dogs and cats

Country Status (12)

Country Link
EP (1) EP1455900A1 (en)
JP (1) JP2005524611A (en)
CN (1) CN1606463A (en)
AR (1) AR037594A1 (en)
AU (1) AU2002348985A1 (en)
BR (1) BR0215070A (en)
CA (1) CA2470995A1 (en)
IL (1) IL162103A0 (en)
NO (1) NO20043008L (en)
PL (1) PL370624A1 (en)
TW (1) TW200301126A (en)
WO (1) WO2003053522A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06012215A (en) * 2004-04-22 2007-04-19 Pfizer Prod Inc Method of stabilizing disordered cefovecin sodium salt.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0395219B1 (en) * 1989-03-30 1998-09-30 Pfizer Inc. Cephalosporins and their homologues, process for their preparation and pharmaceutical compositions
GB9424847D0 (en) * 1994-12-09 1995-02-08 Smithkline Beecham Plc Novel process
GB2300856A (en) * 1995-05-16 1996-11-20 Pfizer Ltd Beta-lactam preparation

Also Published As

Publication number Publication date
TW200301126A (en) 2003-07-01
CA2470995A1 (en) 2003-07-03
CN1606463A (en) 2005-04-13
BR0215070A (en) 2004-11-09
AR037594A1 (en) 2004-11-17
WO2003053522A1 (en) 2003-07-03
PL370624A1 (en) 2005-05-30
EP1455900A1 (en) 2004-09-15
NO20043008L (en) 2004-09-01
AU2002348985A1 (en) 2003-07-09
JP2005524611A (en) 2005-08-18

Similar Documents

Publication Publication Date Title
IL161851A0 (en) Formulations comprising a cephalosporin compound and their use treating bacterial infections in catsand dogs
IL169701A0 (en) The use of bacterial phage-associated lysing proteins for preventing and treating bacterial infections in humans, animals and fowl
HK1072547A1 (en) Compositions and method for treating infection in cattle and swine
IL172224A0 (en) Compositions for treating infection in cattle and swine
ZA200507857B (en) Compositions for treating microbial and parasitic infections in cattle and other animals
EP1578399A4 (en) Methods for rapid identification of pathogens in humans and animals
AU2001294593A1 (en) Method of treating aquatic animals with an antimicrobial agent and chelating agent
EP1531828A4 (en) Methods of treating bacterial infections and diseases associated therewith
NO20025204D0 (en) Compounds and methods for treating and preventing bacterial infections
AU2003279526A1 (en) Identifying and treating vaginal infections
AU8878801A (en) Agent and method of prevention and treatment of cancer in animals
EP1461047A4 (en) Compositions and methods for animal treatment
EP1389972A4 (en) Animal treatment and marking system
AU2003239132A8 (en) Methods and compositions for preventing and treating microbial infections
AU2002358036A1 (en) Methods and compositions for use in pet breeding
AU2002353774A1 (en) Products and methods for treating microbial infections
GB0025556D0 (en) Treatment and prophylaxis of disease and infections of pigs and poultry
IL162103A0 (en) Methods of treating bacterial infections in dogs and cats
AU5388299A (en) Antibodies for use in targeted and temporary treatment of humans and animals
EP1233967A4 (en) Pyridinones to treat and prevent bacterial infections
ZA200500166B (en) Methods of treating microbial infections in humans and animals
AU2003290506A8 (en) Methods and devices for treating severe peripheral bacterial infections
AU2002211637A1 (en) Probiotic compositions and methods against bacterial infection in livestock animals
HUP0301298A3 (en) Anthelminthic agents for the prevention of parasitic infections in humans and animals ii
GB0022210D0 (en) Treatment of infection in animals